Professor Yaolong CHEN MD, M.Sc., M.B.B.S.
Dean, Institute of Health Data Science, Lanzhou University
Co-Director, WHO Collaborating Centre for Guideline Implementation and Knowledge Translation
Chair, GIN Asia
Director, Chinese GRADE Centre
Director, Cochrane Affiliate, Lanzhou University
Convener, Testing Treatments interactive
Dr Yaolong Chen is a guideline methodologist at the Evidence Based Medicine Centre of Lanzhou University. He is the Founding Director of Chinese GRADE Centre and Co-Director of WHO Collaborating Centre for Guideline Implementation and Knowledge Translation. He is also the Chair of GIN Asia (Guideline International Network).
Professor Chen is the Co-Founder and Co-Chair of RIGHT (Reporting Items for Practice Guidelines in Healthcare) working group, and the Co-Founder of Practice Guideline Register Platform (http://www.guidelines-registry.org). He has authored and co-authored more than 260 peer reviewed articles on evidence-based medicine, GRADE and practice guidelines. He has been invited to give numerous presentations in Cochrane colloquiums, GIN conferences and other national and international symposiums. He was involved in the development of more than 100 national and international practice guidelines over the last ten years.
Mo wang,chief physician, visiting scholar at London university , centre for nephrology. Director of Nephrology Department , Children's hospital, Chongqing Medical University. Main research areas are the pathogenesis of hereditary glomerular disease and immune pathogenesis of glomerular diseases in children. Reviewer of Frontiers Psychiatry.
讲座视频:0
论文摘要:1
316
0
0
日期 | 时间 | 会场 | Session | 角色 | 讲题 |
---|---|---|---|---|---|
2021-12-12 | 16:45-17:05 | 罕见病专场 Rare Diseases |
罕见病专场 下午 Rare Diseases(p.m.) |
讲者 Speaker | 如何制定罕见病的循证临床实践指南Evidence-based approach to clinical practice guideline development for rare diseases in children |
2021-12-12 | 17:05-17:20 | 罕见病专场 Rare Diseases |
罕见病专场 下午 Rare Diseases(p.m.) |
讨论 Discussant | 讨论Discussion |